JP2009506114A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009506114A5 JP2009506114A5 JP2008529117A JP2008529117A JP2009506114A5 JP 2009506114 A5 JP2009506114 A5 JP 2009506114A5 JP 2008529117 A JP2008529117 A JP 2008529117A JP 2008529117 A JP2008529117 A JP 2008529117A JP 2009506114 A5 JP2009506114 A5 JP 2009506114A5
- Authority
- JP
- Japan
- Prior art keywords
- solid dispersion
- pharmaceutical composition
- pyridazino
- acetamide
- indole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007962 solid dispersion Substances 0.000 claims 20
- 229920000642 polymer Polymers 0.000 claims 12
- 239000008194 pharmaceutical composition Substances 0.000 claims 9
- HJSQVJOROCIILI-UHFFFAOYSA-N ssr-180,575 Chemical compound O=C1C=2N(C)C3=CC(Cl)=CC=C3C=2C(CC(=O)N(C)C)=NN1C1=CC=CC=C1 HJSQVJOROCIILI-UHFFFAOYSA-N 0.000 claims 8
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims 6
- 230000000087 stabilizing effect Effects 0.000 claims 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 5
- 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 claims 5
- 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 claims 5
- 239000002904 solvent Substances 0.000 claims 5
- 229920000193 polymethacrylate Polymers 0.000 claims 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims 3
- 229920000623 Cellulose acetate phthalate Polymers 0.000 claims 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 3
- 229940081734 cellulose acetate phthalate Drugs 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 239000012527 feed solution Substances 0.000 claims 2
- 229920000639 hydroxypropylmethylcellulose acetate succinate Polymers 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 229920003139 Eudragit® L 100 Polymers 0.000 claims 1
- 102000004300 GABA-A Receptors Human genes 0.000 claims 1
- 108090000839 GABA-A Receptors Proteins 0.000 claims 1
- 208000012902 Nervous system disease Diseases 0.000 claims 1
- 208000025966 Neurological disease Diseases 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 238000004581 coalescence Methods 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 230000004064 dysfunction Effects 0.000 claims 1
- 208000019622 heart disease Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 230000004770 neurodegeneration Effects 0.000 claims 1
- 208000015122 neurodegenerative disease Diseases 0.000 claims 1
- 230000002093 peripheral effect Effects 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 238000005507 spraying Methods 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71215005P | 2005-08-29 | 2005-08-29 | |
| US60/712,150 | 2005-08-29 | ||
| PCT/US2006/033022 WO2007027494A2 (en) | 2005-08-29 | 2006-08-24 | Morphous solid dispersions of 7-chloro-n,n, 5-trimethyl-4-oxo-3-phenyl-3, 5,-dihydro-4h-pyridazino [4, 5-b] indole-1-acetamide |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009506114A JP2009506114A (ja) | 2009-02-12 |
| JP2009506114A5 true JP2009506114A5 (https=) | 2009-06-25 |
| JP5026426B2 JP5026426B2 (ja) | 2012-09-12 |
Family
ID=37499538
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008529117A Expired - Fee Related JP5026426B2 (ja) | 2005-08-29 | 2006-08-24 | ７−クロロ−Ｎ，Ｎ，５−トリメチル−４−オキソ−３−フェニル−３，５−ジヒドロ−４Ｈ−ピリダジノ［４，５−ｂ］インドール−１−アセトアミドのアモルファス固体分散体 |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US7713548B2 (https=) |
| EP (1) | EP1926476B1 (https=) |
| JP (1) | JP5026426B2 (https=) |
| KR (1) | KR20080061354A (https=) |
| CN (1) | CN101272767B (https=) |
| AR (1) | AR055615A1 (https=) |
| AU (1) | AU2006285111B8 (https=) |
| BR (1) | BRPI0615609A2 (https=) |
| CA (1) | CA2619438A1 (https=) |
| CR (1) | CR9750A (https=) |
| DK (1) | DK1926476T3 (https=) |
| EA (1) | EA015715B1 (https=) |
| EC (1) | ECSP088203A (https=) |
| ES (1) | ES2414434T3 (https=) |
| HN (1) | HN2008000360A (https=) |
| HR (1) | HRP20130533T1 (https=) |
| IL (1) | IL189587A (https=) |
| MA (1) | MA29783B1 (https=) |
| ME (1) | ME01560B (https=) |
| NO (1) | NO20081364L (https=) |
| NZ (1) | NZ566313A (https=) |
| PL (1) | PL1926476T3 (https=) |
| PT (1) | PT1926476E (https=) |
| RS (1) | RS52914B (https=) |
| SI (1) | SI1926476T1 (https=) |
| TN (1) | TNSN08069A1 (https=) |
| TW (1) | TWI398250B (https=) |
| UA (1) | UA93517C2 (https=) |
| WO (1) | WO2007027494A2 (https=) |
| ZA (1) | ZA200801893B (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE50453E1 (en) | 2006-04-07 | 2025-06-10 | Vertex Pharmaceuticals Incorporated | Indole derivatives as CFTR modulators |
| EP2674428B1 (en) | 2006-04-07 | 2016-04-06 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-binding cassette transporters |
| CN101702878B (zh) * | 2007-05-11 | 2012-11-28 | 弗·哈夫曼-拉罗切有限公司 | 可溶性差的药物的药物组合物 |
| CA2717326C (en) * | 2008-03-11 | 2018-10-23 | Dr. Reddy's Laboratories Ltd. | Preparation of lenalidomide |
| RU2011110241A (ru) * | 2008-08-18 | 2012-09-27 | САНОФИ-АВЕНТИС Ю.Эс. ЭлЭлСи (US) | СПОСОБ ПОЛУЧЕНИЯ ПОЛИМОРФА 7-ХЛОР-N,N,5-ТРИМЕТИЛ-4-ОКСО-3-ФЕНИЛ-3,5-ДИГИДРО-4Н-ПИРИДАЗИНО[4,5-b]ИНДОЛ-1-АЦЕТАМИДА |
| SI2826776T1 (sl) * | 2010-03-25 | 2021-02-26 | Vertex Pharmaceuticals Incorporated | Trdna disperzija amorfne oblike (R)-1(2,2-difluorobenzo(D)(1,3)dioksol-5-il)-N-(1-(2,3-dihidroksipropil) -6-fluoro-2-(1-hidroksi-2-metilpropan-2-il)-1H-indol-5-il)- ciklopropankarboksamida |
| US8802868B2 (en) | 2010-03-25 | 2014-08-12 | Vertex Pharmaceuticals Incorporated | Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide |
| US9801855B2 (en) | 2012-03-07 | 2017-10-31 | National Institute Of Pharmaceutical Education And Research (Niper) | Nanocrystalline solid dispersion compositions and process of preparation thereof |
| KR101986683B1 (ko) | 2012-12-13 | 2019-06-10 | 한미약품 주식회사 | 테트라졸 유도체를 활성 성분으로 포함하는 용해도가 개선된 고체 분산체 |
| CN105493092A (zh) * | 2013-08-30 | 2016-04-13 | 慧与发展有限责任合伙企业 | 实时移动与模式分布的比较 |
| CN106232144B (zh) * | 2014-03-18 | 2019-12-06 | 武田药品工业株式会社 | 固体分散体 |
| RU2744460C2 (ru) | 2014-04-15 | 2021-03-09 | Вертекс Фармасьютикалз Инкорпорейтед | Фармацевтические композиции для лечения заболеваний, опосредованных муковисцидозным трансмембранным регулятором проводимости |
| EP4049660B1 (en) | 2016-02-29 | 2025-02-19 | F. Hoffmann-La Roche AG | Dosage form compositions comprising an inhibitor of bruton's tyrosine kinase |
| AU2018296476B2 (en) * | 2017-07-04 | 2023-11-02 | Jiangsu Hengrui Medicine Co., Ltd. | Pharmaceutical composition and method for preparing same |
| JP2025008679A (ja) * | 2023-07-05 | 2025-01-20 | 学校法人 名城大学 | 非晶質性化有機化合物を含む複合粒子の製造方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5091381A (en) * | 1991-04-12 | 1992-02-25 | Biomeasure, Inc. | 2H-1,3,4-benzotriazepin-2-ones |
| TW487582B (en) * | 1995-08-11 | 2002-05-21 | Nissan Chemical Ind Ltd | Method for converting sparingly water-soluble medical substance to amorphous state |
| FR2766823B1 (fr) | 1997-07-30 | 1999-10-08 | Synthelabo | Derives de 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b] indole-1-acetamide, leur preparation et leur application en therapeutique |
| ATE364374T1 (de) * | 1997-08-11 | 2007-07-15 | Pfizer Prod Inc | Feste pharmazeutische dispersionen mit erhöhter bioverfügbarkeit |
| AUPP278498A0 (en) * | 1998-04-03 | 1998-04-30 | Australian Nuclear Science & Technology Organisation | Peripheral benzodiazepine receptor binding agents |
| FR2788696B1 (fr) * | 1999-01-26 | 2004-03-05 | Synthelabo | Utilisation de derives de pyridazino [4,5-b] indole-1-acetamide pour la preparation de medicaments destines aux maladies du systeme nerveux central |
| ES2306646T3 (es) | 1999-02-09 | 2008-11-16 | Pfizer Products Inc. | Composiciones de farmacos basicos con biodisponibilidad incrementada. |
| EP1027886B1 (en) | 1999-02-10 | 2008-07-09 | Pfizer Products Inc. | Pharmaceutical solid dispersions |
| ES2310164T3 (es) * | 1999-02-10 | 2009-01-01 | Pfizer Products Inc. | Dispositivo de liberacion controlada por la matriz. |
| EP1120109A3 (en) * | 2000-01-24 | 2002-07-10 | Pfizer Products Inc. | Rapidly disintegrating and fast dissolving solid dosage form |
| FR2829939B3 (fr) * | 2001-09-21 | 2003-11-28 | Sanofi Synthelabo | Utilisation du 7-chloro-n,n,5-trimethyl-4-oxo-3-phenyl-3,5- dihydro-4h-pyridazino(4,5-b)indole-1-acetamide pour la preparation de medicaments destines au traitement de la polyarthrite rhumatoide |
| CL2004001884A1 (es) | 2003-08-04 | 2005-06-03 | Pfizer Prod Inc | Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros. |
| WO2005034999A2 (en) * | 2003-10-10 | 2005-04-21 | Bvm Holding Co. | Composition comprising association complex of a pharmaceutical and a poloxamer |
-
2006
- 2006-08-24 EP EP06802215.1A patent/EP1926476B1/en active Active
- 2006-08-24 NZ NZ566313A patent/NZ566313A/en not_active IP Right Cessation
- 2006-08-24 UA UAA200803944A patent/UA93517C2/ru unknown
- 2006-08-24 PT PT68022151T patent/PT1926476E/pt unknown
- 2006-08-24 ES ES06802215T patent/ES2414434T3/es active Active
- 2006-08-24 HR HRP20130533TT patent/HRP20130533T1/hr unknown
- 2006-08-24 ME MEP-2013-80A patent/ME01560B/me unknown
- 2006-08-24 CA CA002619438A patent/CA2619438A1/en not_active Abandoned
- 2006-08-24 BR BRPI0615609-6A patent/BRPI0615609A2/pt not_active IP Right Cessation
- 2006-08-24 SI SI200631605T patent/SI1926476T1/sl unknown
- 2006-08-24 EA EA200800713A patent/EA015715B1/ru not_active IP Right Cessation
- 2006-08-24 KR KR1020087004952A patent/KR20080061354A/ko not_active Abandoned
- 2006-08-24 PL PL06802215T patent/PL1926476T3/pl unknown
- 2006-08-24 CN CN2006800317142A patent/CN101272767B/zh not_active Expired - Fee Related
- 2006-08-24 JP JP2008529117A patent/JP5026426B2/ja not_active Expired - Fee Related
- 2006-08-24 DK DK06802215.1T patent/DK1926476T3/da active
- 2006-08-24 AU AU2006285111A patent/AU2006285111B8/en not_active Ceased
- 2006-08-24 ZA ZA200801893A patent/ZA200801893B/xx unknown
- 2006-08-24 RS RS20130288A patent/RS52914B/sr unknown
- 2006-08-24 WO PCT/US2006/033022 patent/WO2007027494A2/en not_active Ceased
- 2006-08-28 AR ARP060103739A patent/AR055615A1/es not_active Application Discontinuation
- 2006-08-29 TW TW095131682A patent/TWI398250B/zh not_active IP Right Cessation
-
2008
- 2008-02-12 US US12/029,691 patent/US7713548B2/en not_active Expired - Fee Related
- 2008-02-13 TN TNP2008000069A patent/TNSN08069A1/en unknown
- 2008-02-18 IL IL189587A patent/IL189587A/en not_active IP Right Cessation
- 2008-02-19 EC EC2008008203A patent/ECSP088203A/es unknown
- 2008-02-21 CR CR9750A patent/CR9750A/es unknown
- 2008-02-28 HN HN2008000360A patent/HN2008000360A/es unknown
- 2008-03-14 NO NO20081364A patent/NO20081364L/no not_active Application Discontinuation
- 2008-03-17 MA MA30752A patent/MA29783B1/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009506114A5 (https=) | ||
| US11292793B2 (en) | Solid dispersions of amorphous Lumateperone p-Tosylate | |
| Ren et al. | Piperine-loaded nanoparticles with enhanced dissolution and oral bioavailability for epilepsy control | |
| KR102013440B1 (ko) | Parp 억제제 고체약물제형 및 그 용도 | |
| RU2008148547A (ru) | Фармацевтические композиции, включающие дулоксетина гидрохлорид с замедленным высвобождением | |
| JP2009530416A5 (https=) | ||
| JP2012236837A5 (https=) | ||
| JP2014523445A5 (https=) | ||
| CN103396521B (zh) | 两亲性β-环糊精星型聚合物的合成及其胶束化应用 | |
| WO2016001885A2 (en) | Amorphous form of eliglustat hemitartarate | |
| Salsabila et al. | Recent strategies for improving solubility and oral bioavailability of piperine | |
| Mozafari et al. | Vesicles of yeast cell wall-sitagliptin to alleviate neuroinflammation in Alzheimer's disease | |
| CN104478890B (zh) | 一种全反式维甲酸-喜树碱类抗癌药物偶联物及其制备方法和应用 | |
| CN1265884A (zh) | 口服给药的硝苯吡啶小丸及其制备方法 | |
| TWI398250B (zh) | 非晶形固態分散體 | |
| CN102871950A (zh) | 一种熊果酸固体分散体及其制备方法 | |
| CN101693177A (zh) | 基于超声技术的微球制备方法及其装置 | |
| DE60220057T2 (de) | Indoline und Tetrahydrochinoline als Prodrugs zur Tumorbehandlung | |
| US20170014383A1 (en) | Solid dispersion of indirubin | |
| CN107001302A (zh) | 一类水溶性紫杉烷类衍生物及其用途 | |
| JP2016508489A (ja) | プロトパナキサジオール誘導体、その製造方法及びその応用 | |
| CN106413713B (zh) | 用作药物的吡吲哚对映异构体的药学上可接受的盐 | |
| AU2024292342A1 (en) | Formulations and uses of rock2 inhibitors for als | |
| EP2654723A1 (en) | Solid pharmaceutical dosage forms comprising tadalafil and methods of preparation thereof | |
| CN105777769B (zh) | 一种7-乙基-10-羟基喜树碱的衍生物及其制备方法与应用 |